The aim of our study was to evaluate if the determination of the active isoform 5b of tartrate-resistant acid phosphatase (TRACP 5b) provides the possibility to monitor the effect of local radiotherapy in bone metastases and if TRACP 5b will predict further osseous progression.
Department of Radiooncology, Stiftung Friedrichsheim, Johann Wolfgang Goethe-University Hospital Frankfurt Main, Theodor-Stern Kai 7, D-60590 Frankfurt/Main, Germany. stephan.mose@sbk-vs.de